AMENDMENT No. 3Licence Agreement • September 21st, 2012 • Astrazeneca PLC • Pharmaceutical preparations
LICENSE AGREEMENTLicense Agreement • September 21st, 2012 • Astrazeneca PLC • Pharmaceutical preparations
This Agreement made and entered into this 20th day of April, 1998 by and between SHIONOGI & CO., LTD., a Japanese corporation having its principal place of business at 1-8 Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan (hereinafter referred to as “SHIONOGI”) and ZENECA LIMITED, a U.K. corporation with its registered office at 15 Stanhope Gate, London, W1Y 6LN, England (hereinafter referred to as “ZENECA”)
AMENDMENTAstrazeneca PLC • September 21st, 2012 • Pharmaceutical preparations
This AMENDMENT (hereinafter called the “AMENDMENT”) is made and entered into this 14th day of May, 2002 by and between Shionogi & Co.,Ltd., 1-8 Doshomachi 3-chome, Chuo-ku, Osaka, Japan (hereinafter called “SHIONOGI”) and AstraZeneca UK Limited, a U.K. corporation with its registered office at 15 Stanhope Gate, London, W1K 1LN, England (hereinafter referred to as “ASTRAZENECA”) concerning the LICENSE AGREEMENT dated April 20, 1998 by and between SHIONOGI and ASTRAZENECA (formerly Zeneca Limited) (hereinafter called the “AGREEMENT”).
AMENDMENT NO. 2Licence Agreement • September 21st, 2012 • Astrazeneca PLC • Pharmaceutical preparations
AMENDMENT No. 4Licence Agreement • September 21st, 2012 • Astrazeneca PLC • Pharmaceutical preparations
AMENDMENT No. 5Licence Agreement • September 21st, 2012 • Astrazeneca PLC • Pharmaceutical preparations
